TherapeuticsMD
TXMD
#10751
Rank
C$28.41 M
Marketcap
C$2.46
Share price
1.75%
Change (1 day)
29.60%
Change (1 year)

Operating Margin for TherapeuticsMD (TXMD)

Operating Margin as of November 2026 (TTM): 3.51%

According to TherapeuticsMD's latest financial reports and stock price the company's current Operating Margin is 3.51%. At the end of 2021 the company had an Operating Margin of -172.33%.

Operating Margin history for TherapeuticsMD from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-172.33%-27.85%
2020-238.84%-25.31%
2019-319.78%-59.76%
2018-794.68%71.75%
2017-462.69%-0.77%
2016-466.27%10.25%
2015-422.93%17.78%
2014-359.09%22.38%
2013-293.42%-66.27%
2012-869.95%41.38%
2011-615.32%-33.45%
2010-924.61%-94.06%
2009-15,570.87%
200648.63%30.23%
200537.34%18.04%
200431.64%-20.19%
200339.64%13.74%
200234.85%88.36%
200118.50%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01% 242.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
13.51% 284.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-69.66%-2,084.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
67.46% 1,821.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-43.36%-1,335.33%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.